EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CRISPR technologies for detecting DNA and RNA methylation: Mechanisms, platforms, and translational opportunities

Kaixin Chen, Biyao Yang iD, Rui Sang iD, Wenjie Chen iD, Tingxiu Xiang iD, Fei Deng iD

Bioengineering & Translational Medicine · 2026-11 · 11 (6)

DOI: 10.1002/btm2.70174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 19.08.2026. Verfasst von Kaixin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering University of New South Wales Sydney Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Institute NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA and RNA methylation are key epigenetic and epitranscriptomic modifications involved in gene regulation, genome stability, RNA metabolism, and disease progression. Aberrant methylation patterns in cell‐free DNA and RNA have emerged as valuable biomarkers for cancer detection, disease monitoring, and therapeutic stratification. However, conventional methods such as bisulfite sequencing, methylation‐specific PCR, MeRIP‐seq, SCARLET, and LC–MS/MS often require harsh processing, high sample input, complex instrumentation, or lack site‐specific resolution, limiting their clinical and point‐of‐care applications. CRISPR‐based diagnostics provide a promising alternative by combining programmable nucleic acid recognition with collateral cleavage‐mediated signal amplification. This review summarizes recent CRISPR strategies for detecting DNA and RNA methylation, including chemical conversion‐assisted assays, restriction enzyme‐mediated detection, direct amplification‐free sensing based on methylation‐modulated Cas activity, detection of oxidized cytosine derivatives, reverse transcription‐mediated Cas12 detection of m6A, and structure‐sensitive Cas13 sensing. We highlight how methylation‐dependent sequence conversion, enzyme accessibility, polymerase behavior, and nucleic acid structure can be translated into CRISPR‐readable signals. Finally, we discuss current translational challenges and emerging opportunities in point‐of‐care methylation diagnostics, integrated DNA–RNA profiling, engineered Cas effectors, AI‐guided assay design, and CRISPR‐compatible methylome analysis.

Schlagwörter

Stichwörter der Autor:innen

CRISPR diagnosticsDNA methylationRNA methylationliquid biopsypoint‐of‐care testingtranslational bioengineering

Autor:innen und Institutionen

  • School of Biomedical Engineering University of New South Wales Sydney Australia.
  • Australian Centre for NanoMedicine University of New South Wales Sydney Australia.
  • The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Department of Emergency, The Second Affiliated Hospital Guangzhou Medical University Guangzhou People's Republic of China.
  • Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital Chongqing University Chongqing People's Republic of China.

ORCID-Profile: Biyao Yang, Rui Sang, Wenjie Chen, Tingxiu Xiang, Fei Deng

Förderung

  • Cancer Institute NSW

Zitieren

APA

Chen, K., Yang, B., Sang, R., Chen, W., Xiang, T., & Deng, F. (2026). CRISPR technologies for detecting DNA and RNA methylation: Mechanisms, platforms, and translational opportunities. Bioengineering & Translational Medicine, 11(6). https://doi.org/10.1002/btm2.70174

Vancouver

Chen K, Yang B, Sang R, Chen W, Xiang T, Deng F. CRISPR technologies for detecting DNA and RNA methylation: Mechanisms, platforms, and translational opportunities. Bioengineering & Translational Medicine. 2026;11(6). doi:10.1002/btm2.70174

BibTeX
@article{Chen2026,
  author = {Chen, Kaixin and Yang, Biyao and Sang, Rui and Chen, Wenjie and Xiang, Tingxiu and Deng, Fei},
  title = {CRISPR technologies for detecting DNA and RNA methylation: Mechanisms, platforms, and translational opportunities},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  volume = {11},
  number = {6},
  doi = {10.1002/btm2.70174}
}
Kostenlos starten →